Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study - Wikidata - awgldk - TriplyDB

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

http://www.wikidata.org/entity/Q28190808

about

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19 High residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistance Ticagrelor: molecular discovery to clinical evidence: ticagrelor: a novel antiplatelet agent Suspected clopidogrel resistance in a patient with acute stent thrombosis Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and design Optimizing platelet P2Y12 inhibition for patients undergoing PCI Clopidogrel in the treatment of ischaemic heart disease Clopidogrel: an updated and comprehensive review Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)Contemporary issues in clopidogrel therapy: new evidence shaping clinical practice Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials Acute coronary syndromes: diagnosis and management, part I Clopidogrel: the data, the experience, and the controversies.Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry.Dual antiplatelet therapy duration after the placement of a drug-eluting stent: what are the data?Clopidogrel desensitization: case report and review of published protocols.Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study P2Y12 platelet receptors: importance in percutaneous coronary intervention Triggers, targets and treatments for thrombosis.Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke.Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and cons An algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary intervention.Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy Building the Case for Clopidogrel as a World Health Organization Essential Medicine.Incidence and prevention of ischemic stroke following myocardial infarction: review of current literature.Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals.Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes Platelet P2 receptors: old and new targets for antithrombotic drugs.Early management of ST elevation myocardial infarction: a review of practice.Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerations Pharmacological antithrombotic adjuncts to percutaneous coronary intervention.Systematic review and meta-analysis of optimal P2Y12 blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome Myocardial infarction: contemporary management strategies.Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.

P2860

Q22242057-C56BB577-8BBB-4DAE-8AC6-7156F2483EE1 Q24203035-487618B6-1DE1-430B-B936-4EC4F6191958 Q26801867-3AF62750-1426-4864-B460-26389DBADC76 Q26824850-E9B6E3CC-4F7C-4DD7-A571-628AFFE5398B Q26829967-39C5A908-706D-487D-ACEA-9AC94F05280A Q28196159-EF133F36-612D-4DCF-9F54-4E35E0230FB0 Q28199817-291C79E9-A8E4-4A7D-8DC1-40A45C33A09C Q28200506-57D5A67A-9159-4843-80A5-B3A7A713232A Q28210631-47539B9D-C6E1-49F2-B401-4CF01BF5B68C Q28218094-61CC28A7-7743-4CFD-A0B3-879A02158EAB Q28218576-86B4462A-0A18-43E4-B546-254A5C28A6B8 Q28219411-F2FA8E48-17C1-49BF-A52A-9C101F5439CF Q28219418-1A60E369-7F26-4529-9ACE-65F61CCAE34F Q28221366-A8B0692C-D0DA-46B8-B215-6111D9F1E7CE Q28548148-8AC22772-20AA-46B2-B5B3-5D02E96A86E6 Q30490718-189FC050-F67E-430F-88DC-33C0689346E5 Q30573045-E5D4B8EF-C34D-4A47-B895-F8E608A4403C Q30800602-467EB935-6F61-4FF4-820C-1A7B608DDF5E Q30910604-08D3E5AE-CEAF-42C8-AB84-6ED9C8DF29C3 Q33378440-1F4F49E4-D8CF-4958-91D1-EE8163CC3E39 Q33527547-85B8A622-FD57-4A19-9B0D-950D4079DA96 Q33655109-66D03E86-BC68-411E-8715-49B54861D68B Q33765444-A682B23C-BBAD-41C1-A795-2A4FC982D10F Q33899911-77E26965-AB1F-4142-B322-E4EDE71E2988 Q33911647-BE4E3F24-34AC-493E-AD54-2D3173F5CC42 Q34577974-302A6414-4BCE-4FC2-AB22-932E34EFD58F Q35373698-E64433CA-C8AB-4D9A-B9A5-397834E9ADDD Q35755253-848D00E8-FC78-489D-BD42-CEEBBD767D0C Q35883051-F0B47528-FAE3-48D1-B1C9-5A016529927C Q36556396-59A50D46-644E-4574-9C0E-9AE09C44A228 Q36634214-F9979017-7366-4DBA-AA87-9AC86D2679FE Q36645766-37BFA9D5-F40F-4ABD-B5D3-932465D68B36 Q36691632-8F8C40AE-F379-4FB2-A6A1-695A5B5F2759 Q36739783-E8C4AD96-F464-4448-B8E4-07A9EDA5430E Q36754513-974D35F1-CC42-4CC2-BB68-2C6C021E77F7 Q36787291-2F8F3B3B-4843-4D7B-8CA6-FC3400109C0B Q36841959-31461122-C89B-4EAB-A3F3-DF72E3553A8A Q36863859-8A6A2CAC-D8F0-43D0-8AA9-7FE219DEBF86 Q37155890-F1091E3E-6BD7-4A1F-939A-270FC6686D9F Q37174455-19231810-0361-4D6C-AD05-BEF08B4DEBA3

P2860

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

http://www.wikidata.org/entity/Q28190808

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@ast

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@en

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@nl

type

label

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@ast

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@en

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@nl

prefLabel

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@ast

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@en

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@nl

P1433

Q28190808-627DEC5D-51B6-46CA-A7A3-FB09920FA9C5

P1476

Q28190808-C7B60A4B-36D4-471C-A566-B233EFEF5271

P2093

Q28190808-011AB6D8-8622-4F9B-BC83-A75851A0279A

Q28190808-0F7FECAC-1236-4A3B-85FA-A5F5C5B2063D

Q28190808-11BCDD6A-9AE6-47E5-8EE6-7FE6DB614C40

Q28190808-169798F9-5261-4E4B-AC42-1E1AEB174710

Q28190808-1C217DFB-88FF-46E5-A75B-072158050330

Q28190808-4AF43BDE-76AD-44D2-9950-8D4F09756937

Q28190808-9E7ECA4A-1E3B-4425-A8AD-B834493CF4DA

Q28190808-D27E1613-EC69-4608-95EE-E4D352448882

P304

Q28190808-981104B6-32C8-41CD-AFB1-7368EF48E649

P31

Q28190808-DF4ADFA1-B921-4A78-87CF-7CAC74188F93

P3181

Q28190808-6DF82DB2-7491-4D44-AB6C-6C9E602F2B8D

P356

Q28190808-FB89DD28-17CD-4403-A691-ADE46F9A27A4

P407

Q28190808-450AB967-5F86-4C48-8125-065165A513AA

P433

Q28190808-A90269EC-10FC-4408-809D-56DE0A5E0439

P478

Q28190808-EB6A20D1-23B0-4B97-80ED-940BF527A494

P50

Q28190808-5825FFBE-A893-4723-81A1-F6BA6BB0B2AD

Q28190808-69BB7971-51C3-4424-B981-6E9B6AE94517

P577

Q28190808-BECB9F1E-747E-46FA-A1AF-A28DAC3A2E44

P5875

Q28190808-B25FA610-B98A-4537-BB57-2917C09BB9DA

P698

Q28190808-C11C857C-26EE-4D14-959C-787AF86CCC7F

P921

Q28190808-7357637E-D85E-4F50-A5C8-CFE9EA318822

Q28190808-8445A9D8-9B6E-4D74-A2D8-F6DFD0C46F36

Q28190808-BC5B79EA-1B20-4983-BEB6-6AECD4621012

P3181

P356

JAMA.294.10.1224

P1433

Journal of the American Medical Association

P1476

Effect of clopidogrel pretreat ...... olytics: the PCI-CLARITY study

@en

P2093

Basil S Lewis

http://www.w3.org/2001/XMLSchema#string

C Michael Gibson

http://www.w3.org/2001/XMLSchema#string

Carolyn H McCabe

http://www.w3.org/2001/XMLSchema#string

Christopher P Cannon

http://www.w3.org/2001/XMLSchema#string

Jose L López-Sendón

http://www.w3.org/2001/XMLSchema#string

Marc S Sabatine

http://www.w3.org/2001/XMLSchema#string

Pierre Theroux

http://www.w3.org/2001/XMLSchema#string

Sabina A Murphy

http://www.w3.org/2001/XMLSchema#string

P304

1224-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4040103

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.294.10.1224

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

294

http://www.w3.org/2001/XMLSchema#string

P50

Gilles Montalescot

Eugene Braunwald

P577

2005-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7617149

http://www.w3.org/2001/XMLSchema#string

P698

16143698

http://www.w3.org/2001/XMLSchema#string

P921